NEW YORK (GenomeWeb News) – The German Cancer Research Center, or DFKZ, will use Febit’s Geniom RT Analyzer for its research into the roles of microRNAs in cancer, Febit said today.
Heidelberg-based DFKZ will use the Geniom RT analyzer for microarray analysis of miRNA profiles in biological samples.
Febit said the system can be used to fragment and sort large genomes into smaller fractions, which may then be used as samples in mutation analysis and high-throughput sequencing studies.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.

Sponsored by
Dovetail Genomics

Proximity ligation technology generates multi-dimensional next-generation sequencing data that is proving to solve unmet needs in genomic research. 

Sponsored by
Horizon Discovery

This webinar will provide an in-depth case study demonstrating how reference standards can be used to develop and validate circulating tumor DNA (ctDNA)-based assays.

Sponsored by
Dovetail Genomics

This webinar will discuss a proximity ligation-based method for studying structural variation in formalin-fixed paraffin-embedded (FFPE) tissue.